A5010167836- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Palliative Care and End-of-Life Issues
- Heart Failure Treatment and Management
- Cancer Treatment and Pharmacology
- Family and Patient Care in Intensive Care Units
- Breast Cancer Treatment Studies
- Apelin-related biomedical research
- Cardiovascular and exercise physiology
- Cardiac electrophysiology and arrhythmias
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Pharmacology and Obesity Treatment
- Sports Performance and Training
- Cardiac Health and Mental Health
- Cardiovascular Effects of Exercise
- Cardiovascular Syncope and Autonomic Disorders
- Cardiac Structural Anomalies and Repair
- Kruppel-like factors research
- Poisoning and overdose treatments
- Cardiac Arrest and Resuscitation
- Electroconvulsive Therapy Studies
- Cardiac pacing and defibrillation studies
- Cardiovascular Function and Risk Factors
- Neuroethics, Human Enhancement, Biomedical Innovations
Centro Medico Nacional Siglo XXI
2024
Centro Médico ABC
2024
World Heart Federation
2024
Hospital General Universitario Gregorio Marañón
2011-2018
Universidad Veracruzana
2016
Sociedad Española de Cardiología
2011
Essential thrombocythaemia (ET) is a rare clonal myeloproliferative disorder characterized by sustained elevation in platelet count and megakaryocyte hyperplasia. Anagrelide used the treatment of ET, where it has been shown to reduce count. metabolized cytochrome P450 (CYP) 1A2, previous studies effect food on bioavailability pharmacokinetics anagrelide were conducted prior identification active metabolite, 3-hydroxyanagrelide. The objectives this study determine caffeine its...
End-of-life care is not usually a priority in cardiology departments. We sought to evaluate the changes end-of-life after introduction of do-not-resuscitate (DNR) order protocol.
The influence of new-onset atrial fibrillation (AF) on the long-term prognosis nonagenarians who survive acute myocardial infarction (AMI) has not been demonstrated.Our aim was to study association between AF and AMI.From a total 96 patients aged ≥89 years admitted during 5-year period, 64 (67 %) were discharged alive are focus this study.Mean age 91.0 ± 2.0 years, 39 (61 women. During admission, 9 (14 presented AF, 51 (80 did present 4 (6 had chronic AF. follow-up (mean 2.3 2.6 years; 6.6...
Chronic heart failure continues to be one of the main causes impairment in functioning and quality life people who suffer from it, as well mortality our country around world.Mexico has a high prevalence risk factors for developing failure, such blood pressure, diabetes, obesity, which makes it essential have an evidence-based document that provides recommendations health professionals involved diagnosis treatment these patients.This establishes clinical practice guide (CPG) prepared at...
La enfermedad cardiovascular es la primera causa de muerte en mujer que sobrevive al cáncer mama.La magnitud los efectos cardiotóxicos depende no sólo del tratamiento antineoplásico, sino susceptibilidad individual, está determinada por preexistente y factores riesgo concurrentes, así como las intervenciones prevención, identificación oportuno cardiotoxicidad.La Asociación
The relationship between cancer diagnosis and cardiovascular diseases is complex, with newly diagnosed patients facing a higher risk of coronary disease, heart failure, atrial fibrillation. Compared to the general population, they have two six times more dying from causes. Cardiovascular complications arising chemotherapy radiotherapy, along social healthcare access disparities, complicate collection accurate data on incidence cardiotoxicity in marginalized populations. Among LGBTQ...
Declaration El camino hacia una mejor comprensión